MiR-421 from oral SCC cells promotes angiogenesis by targeting heparan sulfate 2-O-sulfotransferase 1 and activating vascular endothelial growth factor (VEGF)/VEGF receptor 2 signaling in endothelial cells, thereby enhancing tumor progression [82]. This evidence concerns the gene VEGFA and neoplasm.